TYR and dermatitis: Although kojic acid, a 3-hydroxy-4-pyrone compound, remains the most extensively researched TYR inhibitor, its usage has been banned in numerous countries due to adverse effects including dermatitis, carcinogenicity, hepatotoxicity, and unspecified mechanisms.